BIOLOGIC - DC SYSTEM FOR REMOVING CO2 FROM BLOOD

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$50,000.00
Award Year:
1988
Program:
SBIR
Phase:
Phase I
Contract:
n/a
Agency Tracking Number:
7985
Solicitation Year:
n/a
Solicitation Topic Code:
n/a
Solicitation Number:
n/a
Small Business Information
Ash Medical Systems Inc
2701 B Kent Ave, West Lafayett, IN, 47906
Hubzone Owned:
N
Socially and Economically Disadvantaged:
N
Woman Owned:
N
Duns:
n/a
Principal Investigator:
() -
Business Contact:
() -
Research Institution:
n/a
Abstract
THE GOAL OF THIS PROJECT IS TO DEVELOP AN EXTRACORPOREAL DEVICE TO REVOVE LARGE AMOUNTS OF CARBON DIOXIDE (CO2) FROM A RELATIVELY SMALL FLOW RATE OF BLOOD. THIS DECARBOXYLATOR DEVICE COULD HELP SUPPORT PATIENTS WHEN RESPIRATOR FAIL TO REMOVE SUFFICIENT CO2 OR BE USED IN PLACEOF RESPIRATORS IN PATIENTS WITH MODERATE CO2 RETENTION. THE DECARBOXYLATOR SYSTEM WILL BE CREATED BY DEVELOPING A NEW DISPOSABLE PACKAGE FOR THE BIOLOGIC DIALYSIS MACHINE THIS MACHINE IS DESIGNED TO PERFORM DIALYSIS THRU A SINGLE BLOOD ACCESS (SUBCLAVIAN CATHETER OR NEEDLE), USING A PLATEDIALYZER BOTH FOR CHEMICAL CLEARANCE AND FOR PUMPING BLOOD A DISPOABLE PACKAGE (DC PACK) WITH SUSPENSION OF CALCIUM HYDROXYL THAT WILL MOVE THROUGH A SCREEN PLATE DIALYZER IN A TO-AND-FRO MANNER TO MAINTAIN FLUIDITY WILL BE DESIGNED. WITHIN THE DIALYZER, THE CALCIUM HYDROXIDE WILL EXCHANGE ITS HYDROXYL FOR BICARBONATE, REMOVING ALMOST ALL OF THE BLOOD BICARBONATE WITHOUT EXCESSIVE CALCIUM OR HYDROXYL RETURN TO THE BLOOD. IN VITRO TESTS DURING PHASE I WILL DETERMINE THE CO2 REMOVAL RATE, CALCIUM RETURN, AND PH CHANGES CAUSED BY THE BIOLOGIC-DC SYSTEM. THESE STUDIES WILL INDICATE WHETHER THE SYSTEM HAS POTENTIAL FOR ASSISTINGPATIENTS IN RESPIRATORY FAILURE.

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government